Statin and fibrate associated myopathy - Study of eight patients

被引:18
作者
Carvalho, AAS
Lima, UWP
Valiente, RA
机构
[1] Hosp Santa Marcelina, Dept Clin Neurol, Sao Paulo, Brazil
[2] Clin Doencas Neuromusculares, Sao Paulo, Brazil
[3] Hosp Santa Marcelina, Serv Neurol Clin, Sao Paulo, Brazil
关键词
statins; fibrates; myopathy; muscle biopsy; creatine kinase;
D O I
10.1590/S0004-282X2004000200013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lipid-lowering drugs have been occasionally associated with neuromuscular symptoms and muscle biopsy changes. We reported the clinical course and the muscle biopsy in eight patients with hyper-lipoproteinemia, treated with lipid-lowering drugs (statins/fibrates). Five patients had myalgias while; in two cases there was proximal muscle weakness, All patients became asymptomatic after the withdrawal of the drug, although creatine kinase remained elevated. We performed muscle biopsy in six cases from three months to two years after suspension of the drug. We found variation in fibers diameters in all cases, with necrosis of fibers in five cases, inflammatory infiltration in one case, the presence of vacuolated fiber in one patient and ragged-red fibers in three subjects. We concluded that although the muscle biopsy findings were not specific, the prolonged use of statins and or fibrates might induce a chronic myopathy even in the absence of symptoms.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 18 条
[1]  
ARGOV Z, 2000, STRUCTURAL MOL BASIS, P245
[2]   MITOCHONDRIAL MYOPATHY - A RESULT OF CLOFIBRATE ETOFIBRATE TREATMENT [J].
BARDOSI, A ;
SCHEIDT, P ;
GOEBEL, HH .
ACTA NEUROPATHOLOGICA, 1985, 68 (02) :164-168
[3]  
Dubowitz V., 1985, MUSCLE BIOPSY PRACTI
[4]   MITOCHONDRIAL MYOPATHY DEVELOPING ON TREATMENT WITH THE HMG COA REDUCTASE INHIBITORS - SIMVASTATIN AND PRAVASTATIN [J].
ENGLAND, JDF ;
WALSH, JC ;
STEWART, P ;
BOYD, I ;
ROHAN, A ;
HALMAGYI, GM .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (04) :374-375
[5]   The myotoxicity of statins [J].
Evans, M ;
Rees, A .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (04) :415-420
[6]   Lipid-lowering drugs and risk of myopathy:: A population based follow-up study [J].
Gaist, D ;
Rodríguez, LAG ;
Huerta, C ;
Hallas, J ;
Sindrup, SH .
EPIDEMIOLOGY, 2001, 12 (05) :565-569
[7]  
GALIANA J, 1995, REV CLIN ESP, V195, P620
[8]   Polymyositis associated with simvastatin [J].
Giordano, N ;
Senesi, M ;
Mattii, G ;
Battisti, E ;
Villanova, M ;
Gennari, C .
LANCET, 1997, 349 (9065) :1600-1601
[9]   Statin-associated myopathy [J].
Hamilton-Craig, I .
MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (09) :486-+
[10]   Rhabdomyolysis with HMG CoA reductase inhibitors: a class effect? [J].
Langford, NJ ;
Kendall, MJ .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (06) :391-395